
OPKO Health OPK
€ 1.03
0.86%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
694 M |
Marktkapitalisierung |
$ 854 M |
EBITDA (LTM) |
$ -79.8 M |
P/E (LTM) |
-4.81 |
P/S (LTM) |
1.31 |
EPS (LTM) |
-0.26 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
$ 2.81 | -5.39 % | $ 91.2 K | Nasdaq Capital Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 23.0 | -1.5 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 28.5 | -8.06 % | $ 307 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.13 | -3.26 % | $ 1.44 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 32.44 | 0.22 % | $ 901 M | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 218.83 | -0.41 % | $ 160 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 101.7 | -2.37 % | $ 4.01 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 206.95 | 0.83 % | $ 23 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 68.33 | 0.24 % | $ 26.4 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.43 | -5.57 % | $ 1.04 B | Nasdaq Global Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 10.4 | -4.76 % | $ 295 M | Nasdaq Capital Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.37 | 0.02 % | $ 19.2 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.82 | - | $ 7.98 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 22.74 | -1.41 % | $ 688 M | Nasdaq Global Market | ||
|
Lantheus Holdings
LNTH
|
$ 66.24 | -1.39 % | $ 4.58 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 104.16 | -0.83 % | $ 12.8 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Mettler-Toledo International
MTD
|
$ 1 400.6 | 0.04 % | $ 28.9 B | NYSE,SPB | ||
|
NeoGenomics
NEO
|
$ 11.36 | -1.26 % | $ 1.44 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Natera
NTRA
|
$ 206.93 | -2.23 % | $ 20.4 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 165.55 | -8.67 % | $ 8.51 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 645.07 | -0.23 % | $ 53.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 117.29 | -1.7 % | $ 18.6 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 177.19 | -2.89 % | $ 32.1 B | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 31.87 | -3.2 % | $ 20 B | NYSE | ||
|
Biodesix
BDSX
|
$ 10.18 | -2.12 % | $ 1.32 B | Nasdaq Global Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 286.87 | 0.86 % | $ 24.1 B | NYSE,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.7 | -0.77 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 131.48 | -9.05 % | $ 10.8 B | Nasdaq Global Select Market,SPB | ||
|
Quidel Corporation
QDEL
|
$ 27.58 | -5.6 % | $ 1.16 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.23 | -3.88 % | $ 5.12 M | Nasdaq Capital Market |